![Christopher Vann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Vann
Direttore operativo presso
AUTOLUS THERAPEUTICS PLC
Patrimonio netto: 307 538 $ in data 30/06/2026
Profilo
Christopher Vann currently works at Alliance for Regenerative Medicine, as Treasurer & Director from 2023 and Autolus Therapeutics Plc, as Chief Operating Officer & Senior Vice President from 2016.
Mr. Vann also formerly worked at Roche Holding AG, as Commercial Director from 1994 to 2016.
Mr. Vann received his undergraduate degree from School of Pharmacy.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/03/2026 | 192.211 ( 0,12% ) | 307 538 $ | 30/06/2026 |
Posizioni attive di Christopher Vann
| Società | Posizione | Inizio |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Direttore operativo | 01/10/2016 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Direttore/Membro del Consiglio | 01/01/2021 |
Precedenti posizioni note di Christopher Vann
| Società | Posizione | Fine |
|---|---|---|
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/09/2016 |
Formazione di Christopher Vann
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
65
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
School of Pharmacy
 School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
